Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

(Em)powering the future – GF Piping Systems enters the battery manufacturing market

Swiss flow solutions provider GF Piping Systems is applying its knowledge of lightweight and corrosion-free systems to the needs of the battery sector, focusing on applications from energy-efficient cooling and water treatment to process automation. The company will attend the Battery Show event, from 23 to 25 May 2023 in Stuttgart, Germany.The battery industry plays an essential role in facilitating the transition towards a decarbonized future – in Europe alone, new production capacities of around 1.4 TWh of battery cell capacity per year are expected by 2030. However, it is crucial to

Katalysen Ventures AB announces venture development agreement for IPO project in Manico AB

Katalysen Ventures AB (publ) ("Katalysen") and Manico AB ("Manico") have announced a venture development agreement to prepare for Manico's upcoming IPO, in addition to Katalysen exercising options and acquiring new shares worth SEK 925 950 in Manico.Manico is a leading provider of cutting-edge software and hardware for educational purposes, with a proprietary software on touch screens that enables collaboration between multiple users at the same time. Manico serves a diverse range of clients, including schools, elderly homes, museums, hospitals, hotels, shopping malls, restaurants, and more.

BioStock: BrainCool’s CEO on the purchase agreement in the US

BrainCool has signed a purchase agreement for IQool System with Vanderbilt Health in the US. The aim is to make the medical device available in the 74 hospitals that are part of that health system. BioStock talked to BrainCool’s CEO Martin Waleij about the agreement and its potential commercial benefits.Read the full interview with Martin Waleij at biostock.se: https://www.biostock.se/en/2023/05/braincools-ceo-on-the-purchase-agreement-in-the-us/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Pia Marions, former Carnegie CFO, is to be appointed to the board of directors of Carnegie Group

Pia Marions and Gustav Axelson is to be appointed as new directors of Carnegie Holding AB (Carnegie Group) and Carnegie Investment Bank AB.Ms Marions has many years of experience in the financial industry, most recently as CFO of Skandia. She served as the CFO of Carnegie from 2010 to 2015. “I am delighted that Pia is returning to Carnegie as a director. She thoroughly understands the company, its culture and the driving forces that make Carnegie one of the foremost advisers and asset managers in the Nordics,” says Carnegie Group Board Chair Anders Johnsson. “With her in-depth and

Salmon Evolution ASA: Invitation to presentation of first quarter 2023 results

Salmon Evolution will present its first quarter 2023 results, followed by a Q&A session, on Tuesday, 23 May 2023, at Hotel Continental in Oslo at 08:00 CET. A taste of our delicious locally smoked salmon from Indre Harøy will be served from 07:45 CET. Participants may also follow the presentation and submit questions through a live webcast available on www.salmonevolution.no, or with the following link: https://events.webcast.no/viewer-registration/OGhLeEcM/register 

SimCorp A/S - Major shareholder announcement

May 16, 2023 Company announcement no 9/2023Pursuant to Section 30 of the Capital Markets Act, please be informed that SimCorp A/S on May 15, 2023, was informed by BLS Capital Fondsmæglerselskab A/S that BLS Capital Fondsmæglerselskab A/S now holds 8.95% of the voting rights in SimCorp A/S. The shares are traded at NASDAQ Copenhagen A/S. Questions may be addressed to Anders Hjort, VP, Head of Investor Relations, SimCorp A/S (+45 3544 8800).

NRC Group ASA - Appointed to a maintenance contract in Finland - EUR 14,3 million

Finnish Transport Infrastructure Agency (FTIA) has appointed NRC Group Finland, a company wholly owned by NRC Group ASA, to a contract for track and signalling maintenance on maintenance area 9, which ranges from Oulu to Kokkola and Iisalmi. The contract is valued at approximately EUR 14,3 million. The work will commence in November 2023, and is scheduled for completion in October 2026, with an additional 2+2 option period. Closing date for submission of complaints is 14 days from today, and formal contractual signing can take place after this period at the earliest. For further

DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today

COPENHAGEN, Denmark, 16 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announces that Today is the first day of the exercise period for DanCann Pharma’s warrants of series TO 2 which were issued in connection with the Company’s rights issue of units that was announced on 21 October 2022.  Holders of warrants of series TO 2 have, for each warrant, the right to subscribe for one (1) new share in DanCann Pharma at a price of DKK 0.36 per share. The exercise period runs until and including 31 May 2023.Information

Former U.S. White House Surgeon and FDA Medical Officer joins Bioretec team

Bioretec Ltd    Press release        16 May 2023 at 10:00 a.m. EESTBioretec Ltd, a pioneer in bioresorbable orthopedic implants, announces that Dr. Jeremy Dublon joins the Bioretec team to support Company’s U.S. commercialization strategy from a clinical and regulatory perspective. Dr. Dublon joins the Bioretec team as a Regulatory Advisor. Dr. Dublon is a board-certified podiatric surgeon specializing in diagnosing and treating conditions in the foot and ankle of people of all ages. In addition, he has specialized training and education in podiatric medicine, surgery, and orthopedics.

Wärtsilä and Corsica Linea sign agreement to ensure optimal performance for new ferry

Wärtsilä Corporation, Trade press release, 16 May 2023 at 10 AMTechnology group Wärtsilä has signed a ten-year Guaranteed Asset Performance (GAP) agreement  with French ferry operator Corsica Linea. The agreement is designed to ensure optimal performance of the power systems onboard the company’s new LNG-fuelled ‘A Galeotta’ RoPax vessel, which will sail between Marseille and Corsica in France. The 206-metre-long ship was built at the Visentini yard in Italy. It features two Wärtsilä 50DF dual-fuel main engines and two Wärtsilä 20DF dual-fuel auxiliary engines.

Finnish Innovation Index: Paulig named as one of the top 10 most innovative companies in Finland

Paulig has been named among the top 10 most innovative companies in Finland according to an annual ranking conducted by Hanken School of Economics. The Finnish Innovation Index (FII) is a national indicator, which focuses on Finnish consumers’ perception of companies’ innovativeness and attractiveness, based on their experiences. “We are honored to have received this recognition, especially as it comes directly from the Finnish consumers. Innovation plays an important role in the development of our product portfolio as well as our sustainability actions and operations in general -

Volvo Group launches world’s first electric truck safety app with AR technology for first responders

Building on its long heritage of safety innovations, Volvo Group is the first truck manufacturer to launch an Augmented Reality (AR) safety app for electric trucks, designed specifically to support first responders in an emergency. The app is developed to deliver instant, valuable information from the electric truck to the emergency services team arriving on the scene to guide them in real-time and ensure safe rescue conditions.Electric trucks will change the world, not only in terms of making transportation more sustainable, but also in how we drive and interact with the trucks themselves.

Finnair addresses the excess carry-on baggage issue with the new Superlight ticket type and changes to baggage allowances

Finnair is introducing a new Superlight ticket for journeys within Europe and making changes to its baggage allowances as of 1 June. Excess amounts of carry-on baggage cause delays in boarding and impact both punctuality of flights and travel comfort. The changes are designed to address the issue of excess carry-on baggage on board, which is also a frequent feedback item from customers.  As of 1 June, the Superlight ticket type will replace Economy Light tickets on Finnair journeys within Europe. It includes a small bag, which goes under the seat, but no other carry-baggage. Any

New contract for CSV Normand Pacific within renewable energy

Solstad Offshore ASA is pleased to announce that Prysmian Powerlink Srl (“Prysmian”) has entered into a new 7-year contract for the CSV Normand Pacific. The contract is firm until 31 December 2030. In addition, Prysmian has the option to extend the contract with 2 x 2 years and 1 x 1 year beyond the firm period. Normand Pacific has been on charter with Prysmian since 2016 and the vessel is supporting the installation of power cable systems on Prysmian’s global projects. Skudeneshavn, 16 May 2023 ContactsLars Peder Solstad CEO, at +47 91 31 85 85Kjetil Ramstad CFO, at +47 90 75

Normet announces tender offer results for its outstanding capital securities issued in 2020

Normet Group Ltd.           Press release  16 May 2023 at 9:50 EEST NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Normet announces tender offer results for its outstanding capital securities issued in 2020 Normet Group Ltd. (“Normet” or the “Company” and together with its subsidiaries “Normet Group”) announces today the results of the

BioStock: Circio's CEO on the new strategy

Circio, formerly known as Targovax, is a Norwegian immunotherapy company within RNA-based therapeutics. The company is focusing on circular RNA, which holds several advantages over mRNA, according to CEO Erik Digman Wiklund. The potential of circular RNA has been acknowledged by the industry, as the area is attracting a lot of interest and investments.Watch the interview with Circio's CEO Erik Digman Wiklund at biostock.se. https://www.biostock.se/en/2023/05/circios-ceo-on-the-new-strategy/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.

ICA Gruppen issues green bonds

ICA Gruppen has successfully completed a green bond issue of SEK 3.5 billion under the company’s Swedish MTN programme.The issue saw strong demand and was more than 1.5 times oversubscribed. The bonds of SEK 1.25 billion and SEK 2.25 billion were issued with tenors of 3 and 5 years respectively, both tenors with fixed and floating rate tranches. This represents ICA Gruppen’s first green bond issue, following the company's recently established Green Finance Framework, developed to align with the ICMA Green Bond Principles. CICERO Shades of Green, now part of S&P Global, has provided a

Investor’s Head of Corporate Communication & Sustainability Viveka Hirdman-Ryrberg steps down

Viveka Hirdman-Ryrberg, age 60, has decided to step down after close to five years at Investor and more than 30 years within the Wallenberg sphere.“Viveka has been instrumental in setting and driving our sustainability strategy as well as gearing up our communication work. She is a true change agent that gets things done and has been a much-appreciated colleague. While highly regrettable, I have full respect for her decision and wish her all the best going forward,” says Johan Forssell, Investor’s President and CEO.“It has been a great privilege to be a part of the fantastic Investor

DDM Holding AG and DDM Debt AB to report first quarter 2023

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM Debt 2026) will publish their Q1 2023 reports on Tuesday 30 May 2023 at 08:00 CEST. Dr. Andreas Tuczka, Executive Chairman, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CEST, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or via teleconference with prior registration at: https://

DDM Holding AG and DDM Debt AB to report first quarter 2023

DDM Holding AG (First North Growth Market: DDM) and its subsidiary DDM Debt AB (Nasdaq Stockholm: DDM Debt 2026) will publish their Q1 2023 reports on Tuesday 30 May 2023 at 08:00 CEST. Dr. Andreas Tuczka, Executive Chairman, and Mr. Fredrik Olsson, CFO, will host a conference call the same day, beginning at 10:00 CEST, to present and comment on the DDM Group’s financial results. The conference will be held in English and can be followed live on www.ddm-group.ch  or via teleconference with prior registration at: https://

Valmet signs a service agreement with UBE Corporation in Spain

Valmet Oyj’s trade press release on May 16, 2023 at 9:30 a.m. EESTValmet and UBE Corporation Europe S.A.U. have signed a service agreement to improve the waste boiler’s performance at UBE’s chemical plant in Castellón, Spain. The agreement was included in Valmet's orders received of the first quarter 2023 and was effective immediately. The value of the agreement will not be disclosed. Through the service agreement UBE is expecting to utilize Valmet’s support in optimizing the boiler’s availability and performance as well as developing the inspection and maintenance practices further.

Cline Scientific announces Letter of Intent with NecstGen for the manufacture of its stem cell therapy for damaged cartilage

Mölndal, Sweden and Leiden Netherlands, - Cline Scientific, a Swedish life science company developing a novel regenerative medicine, and NecstGen, a CDMO and centre of excellence for Cell and Gene Therapy, have signed a Letter of Intent to develop and manufacture clinical batches of Cline’s cell therapy for cartilage repair, StemCART.Through this intended partnership, NecstGen will support the further development and manufacture of Cline’s cell therapy for damaged cartilage, StemCART. StemCART is an Advanced Therapy Medicinal Product (ATMP) that aims to revolutionize the treatment of

ExpreS2ion announces financial results for the first quarter 2023

Hørsholm, Denmark, 16 May 2023– ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its first quarter financial results for 2023. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments “In the first quarter of 2023, we made significant progress and secured additional funding for our pipeline-driven strategy, while also strengthening our organisation and improving access to valuable scientific knowledge in the field of infectious diseases. Overall, our outlook for the

There are no items matching the current filter
There are no more items matching the current filter
Back to top